These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11402851)

  • 1. [Expression of galectin-3 in thyroid gland and follicular cell tumors of the thyroid. A critical study of its possible role in preoperative differential diagnosis].
    Niedobitek C; Niedobitek F; Lindenberg G; Bachler B; Neudeck H; Zuschneid W; Hopfenmüller W
    Pathologe; 2001 May; 22(3):205-13. PubMed ID: 11402851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J
    Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
    Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland].
    Iushkov PV; Antonova SS; Bartolazzi A
    Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
    Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K; Matsushita Y; Yonezawa S; Nakano S; Shirao K; Natsugoe S; Sueyoshi K; Aikou T; Sato E
    Hum Pathol; 2000 Apr; 31(4):428-33. PubMed ID: 10821488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential.
    Papotti M; Rodriguez J; De Pompa R; Bartolazzi A; Rosai J
    Mod Pathol; 2005 Apr; 18(4):541-6. PubMed ID: 15529186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
    Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiated thyroid gland carcinomas in "autonomous adenomas" in childhood].
    Müller A; Goretzki P; Witte J; Gerharz P; Röher HD
    Chirurg; 1995 Oct; 66(10):1018-20. PubMed ID: 8529444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
    Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
    Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.
    Prasad ML; Pellegata NS; Huang Y; Nagaraja HN; de la Chapelle A; Kloos RT
    Mod Pathol; 2005 Jan; 18(1):48-57. PubMed ID: 15272279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.
    Cvejić D; Savin S; Petrović I; Paunović I; Tatić S; Havelka M
    Acta Chir Iugosl; 2003; 50(3):67-70. PubMed ID: 15179758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.